Cosmeceutical Claims May Be Headed Into FDA's Radar
This article was originally published in The Tan Sheet
Executive Summary
FDA under the Obama administration may cast a sharper eye on cosmeceuticals than the agency has in years past, according to Georgia C. Ravitz, a food and drug law lawyer at Arent Fox
You may also be interested in...
Beauty Claims "Blur" Difference From Drugs As Cosmeceutical Market Grows
Analysts agree cosmeceuticals remain a promising growth vehicle despite the notable regulatory questions the products can create.
FDA Warning To Skin Care Firm Shows Perils Of Cosmetics-To-OTC Transition
FDA's warning letter saying skin care product firm MW Laboratories marketed unapproved new drugs illustrates the potentially perilous transition from offering cosmeceuticals to marketing OTC drugs
No Concealing Cosmeceutical Claims From NAD, FTC
Claims for cosmeceuticals referred by the National Advertising Division go to the same place on the Federal Trade Commission's list of priorities as other disputed claims - straight to the top